sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology
The Vanguard Group, Inc. has filed a Form 8.3 with the Irish Takeover Panel concerning its position in Mural Oncology plc. This disclosure, dated September 26, 2025, outlines Vanguard's interests in Mural Oncology's securities. Notably, Vanguard controls 646,536 ordinary shares, which equates to a 3.74% stake in the company.
In recent activity, Vanguard purchased 32 ordinary shares at a unit price of $2.09. This purchase is part of routine transactions disclosed under the Irish Takeover Panel rules. No additional derivatives or options have been noted in the filing. Furthermore, there are no indemnity, option arrangements, or agreements affecting the voting or future securities dealings reported by Vanguard.
The disclosure, as per the Irish regulations, confirms Vanguard's position in the securities market regarding Mural Oncology. No supplemental Form 8 has been attached to this filing.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.